Skip to content

Humanized CD28 monoclonal antibody ELISA Kit 60005

$570.00

Summary

  • ELISA kit for research use (RUO)
  • Reactivity: Humanized CD28 mAb
  • Suitable for: ELISA
  • Time:3 hours
  • Sample types:Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
SKU: 60005 Category: Tags: , ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Humanized CD28 mAb

species reactivity

Human

applications

Indirect ELISA Sandwich

assay type

Indirect & quantitative

available size

96 tests

sensitivity

0.281ng/ml

range

0.469-30ng/ml

Humanized CD28 monoclonal antibody ELISA Kit

kit
Assay type
ELISA
Research area
biologic
Sample type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Components
Break apart microtiter test strips each coated single wells 8 x 12 (96 Total)
Lyophilized Standard2 x vial
HRP Antibody(Concentrated, 100X)120 uL
Washing solution concentrate (25X)30 mL
Sample Dilution buffer20 mL
Antibody Dilution buffer10 mL
Stopping solution10 mL
TMB Substrate (ready-to-use)10 mL
Plate seals3
Storage
Store at 2-8°C.
target relevance
Homo sapiens CD28
T-cell-specific surface glycoprotein CD28
Protein names
T-cell-specific surface glycoprotein CD28
Alternative names
TP44
Gene names
CD28
Function
Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed:1650475, PubMed:7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed:24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell subsets (PubMed:12196291, PubMed:1650475, PubMed:35397202). Mechanistically, ligation induces recruitment of protein kinase C-theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both PI3K/Akt-dependent and -independent pathways (PubMed:21964608, PubMed:24665965, PubMed:7568038). In conjunction with TCR/CD3 ligation and CD40L costimulation, enhances the production of IL4 and IL10 in T-cells (PubMed:8617933)
Subcellular location
Cell surface
Structure
Interacts with CD40LG
Post-translational modification
Phosphorylated by LCK (PubMed:7568038). Dephosphorylated by PTPN11 (PubMed:36114179)
Tyrosine phosphorylated induced by CD40LG
Involvement in disease
Immunodeficiency 123 with HPV-related verrucosis
An autosomal recessive immunologic disorder characterized by susceptibility to human papilloma virus (HPV) infections and the development of HPV-related common verrucosis in the first decade of life. In some patients with HPV2 infection, warts may progress to severe generalized hyperkeratotic cutaneous papillomatosis with cutaneous horns ('tree-man' phenotype). In patients with HPV4 infection, warts remains stable and may even regress with age.

Keywords
3D-structure, Alternative splicing, Cell membrane, Disease variant, Disulfide bond, Glycoprotein, Immunoglobulin domain, Membrane, Phosphoprotein, Proteomics identification, Receptor, Reference proteome, Signal, Transmembrane, Transmembrane helix
Sequence
MLRLLLALNLFPSIQVTGNKILVKQSPMLVAYDNAVNLSCKYSYNLFSREFRASLHKGLD SAVEVCVVYGNYSQQLQVYSKTGFNCDGKLGNESVTFYLQNLYVNQTDIYFCKIEVMYPP PYLDNEKSNGTIIHVKGKHLCPSPLFPGPSKPFWVLVVVGGVLACYSLLVTVAFIIFWVR SKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRS
UniProt accession: P10747

Data

Standard Curve

X axis: log | Y axis: linear
Standard STD [ng/mL] OD1 OD2 Average OD Corrected OD
Blank #8 0 0.04 0.04 0.04 0
Standard #7 0.47 0.19 0.19 0.19 0.15
Standard #6 0.94 0.33 0.34 0.33 0.29
Standard #5 1.88 0.43 0.45 0.44 0.4
Standard #4 3.75 0.64 0.66 0.65 0.61
Standard #3 7.5 1.01 1.04 1.02 0.98
Standard #2 15 1.56 1.61 1.59 1.54
Standard #1 30 2.08 2.14 2.11 2.07

Precision

Sample n Mean Standard Deviation CV (%)
Intra Sample 1 20 0.94 0.05 5.21
Intra Sample 2 20 3.72 0.18 4.89
Intra Sample 3 20 15.11 0.75 4.99
Inter Sample 1 20 1 0.05 5.41
Inter Sample 2 20 3.87 0.2 5.18
Inter Sample 3 20 14.8 0.7 4.76

Recovery

Matrix Recovery Range (%) Average (%)
Serum(n=5) 85-99 92
EDTA Plasma(n=5) 87-104 97
HeparinPlasma(n=5) 88-104 98

Stability

37°C 1 Month (%) 2–8°C 6 Months (%) 2–8°C 12 Months (%)
80 95-100 85-98

Linearity

Sample 1:2 Dilution (%) 1:4 Dilution (%) 1:8 Dilution (%)
Serum(n=5) 90-105% 85-98% 86-96%
EDTAPlasma(n=5) 85-95% 88-101% 92-100%
Heparin Plasma(n=5) 90-103% 85-101% 85-100%

FAQ & Publications

Publications
pmid title authors citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

Relevant to this product
View Protocol  |  View PDF

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.